We are live on ! Find out more
TDAC

Translational Development Acquisition Corp

41 hedge funds and large institutions have $156M invested in Translational Development Acquisition Corp in 2025 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 11 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

9% more capital invested

Capital invested by funds: $142M → $156M (+$13.3M)

8% more funds holding

Funds holding: 3841 (+3)

7.67% more ownership

Funds ownership: 80.93%88.59% (+7.7%)

55% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 11

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
41
Holders Change
+3
Holders Change %
+7.89%
% of All Funds
0.54%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
4
Increased
5
Reduced
11
Closed
1
Calls
$28K
Puts
Net Calls
+$28K
Net Calls Change
+$4K

TDAC Hedge Fund Activity: Q3 2025 in Review

41 of the 7,631 institutional investors tracked by Wall St. Rank reported a position in Translational Development Acquisition Corp (TDAC) for Q3 2025, worth a combined $156M — up 9.3% from $142M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new TDAC positions and 1 closed out — a net gain of 3 holders — while 5 added to existing stakes and 11 trimmed.

The largest buyer was Rivernorth Capital Management, opening a new position worth an estimated $4.13M. The largest seller was Mizuho Securities USA, cutting an estimated $1.94M.

  • 41 institutional investors held Translational Development Acquisition Corp (TDAC) as of Q3 2025, up from 38 in Q2 2025.
  • Funds reported $156M of Translational Development Acquisition Corp stock for Q3 2025, up 9.3% quarter-over-quarter.
  • 4 funds opened new Translational Development Acquisition Corp positions in Q3 2025 and 1 closed out, a net change of +3 holders.
  • The largest Translational Development Acquisition Corp buyer in Q3 2025 was Rivernorth Capital Management, an estimated $4.13M added.
  • The largest Translational Development Acquisition Corp seller in Q3 2025 was Mizuho Securities USA, an estimated $1.94M sold.

Based on aggregated 13F filings for Q3 2025.